Giancarlo Cappellini - CONSULENTE INFORMATICO - PRISMA SOFTWARE SRL | LinkedIn
Genomic Classification of Cutaneous Melanoma - University of Miami
TRIDENT analysis of melanoma vs control sera.
ioo;;-~~ ." - ,
Genomic Classification of Cutaneous Melanoma. - Abstract - Europe PMC
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
Differential Denaturation of Serum Proteome Reveals a Significant Amount of Hidden Information in Complex Mixtures of Proteins | PLOS ONE
Dr. David N. Hayes, MD | Memphis, TN | Oncologist | US News Doctors
Ecco i finalisti del Premio Roma di letteratura - Il Faro Online
Frontiers | Immune Check Point Inhibitors in Primary Cutaneous T-Cell Lymphomas: Biologic Rationale, Clinical Results and Future Perspectives
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma – topic of research paper in Clinical medicine. Download scholarly article PDF
Giancarlo Antonini-Cappellini's research works
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
Immunological validation of α2MB, Apo E and Apo A1 as potential diagnostic biomarkers.
Gian CAPPELLINI | Istituto Dermopatico dell'Immacolata, Rome | IDI | Oncologia
Circulating miR-1246 and miR-485-3p as Promising Biomarkers of Clinical Response and Outcome in Melanoma Patients Treated with T
Giancarlo Antonini (@gcarloantonini) / Twitter
7 perfiles de «Carlo Cappellini» | LinkedIn
Giancarlo Antonini (@gcarloantonini) / Twitter
Giancarlo Antonini (@gcarloantonini) / Twitter
Investigating Serum and Tissue Expression Identified a Cytokine/Chemokine Signature as a Highly Effective Melanoma Marker
gian carlo antonini cappellini - Oncologist - Ospedale Sandro Pertini - ASL RM2 | LinkedIn
Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing in: European Journal of Endocrinology Volume 182 Issue 1 (2020)
Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma | Journal of Translational Medicine | Full Text
